Mobile Stroke Units: Field Imaging and Triage for Acute Stroke Emergencies
Anne W. Alexandrov,Nitin Goyal,Abhi Pandhi,Sarah McCormick,Andrei V. Alexandrov,Adam Arthur
DOI: https://doi.org/10.1007/978-3-319-99016-3_35
2019-01-01
Abstract:Stroke is a pandemic affecting people of all populations and ages. In the past few decades, the global stroke burden has increased significantly worldwide especially between the years 1990 and 2013 (Feigin VL, Norrving B, George MG et al, Nat Rev Neurol 12(9):501–512, 2016). Currently available acute ischemic stroke (AIS) treatments are intravenous recombinant tissue plasminogen activator (rtPA) and, in the case of emergent large vessel occlusion (ELVO), mechanical thrombectomy (MT) (The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, N Engl J Med 333(24):1581–1587, 1995; Berkhemer OA, Fransen PS, Beumer D et al, N Engl J Med 372(1):11–20, 2015; Goyal M, Demchuk AM, Menon BK et al, N Engl J Med 372(11):1019–1030, 2015; Campbell BC, Mitchell PJ, Kleinig TJ et al, N Engl J Med 372(11):1009–1018. 10.1056/NEJMoa1414792, 2015; Saver JL, Goyal M, Bonafe A et al, N Engl J Med 372(24):2285–2295, 2015; Jovin TG, Chamorro A, Cobo E et al, N Engl J Med 372(24):2296–2306, 2015); however, few patients receive these time-dependent treatments. The concept of taking stroke care to the patient by deployment of mobile stroke units (MSU) is gaining momentum. In this chapter, we explore the use of AIS treatments, management of contributors to treatment delays, and the history and utility of MSUs to support acute stroke treatment.